Our mission

Our mission is to enhance existing screening programmes and establish new ones by conducting clinical trials and studies focused on cancer prevention, early diagnosis, and screening.

The CPTU’s primary objectives are to facilitate high-quality clinical trials and well-designed studies that prevent cancer by detecting pre-cancerous lesions, promote early cancer diagnosis through screening, and advance cancer prevention through medicinal treatments with fewer side effects and behavioural interventions.

We support investigators at Queen Mary University of London and across the UK. Our work includes evaluating existing screening programmes and exploring new technologies and innovations that have the potential to create or improve screening methods.

By optimising the efficacy and cost-effectiveness of screening programmes while minimising associated harms, we aim to advance stratified screening and better integrate population-wide screening with targeted early diagnosis.